0001104659-12-046297.txt : 20120627
0001104659-12-046297.hdr.sgml : 20120627
20120627170043
ACCESSION NUMBER: 0001104659-12-046297
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120625
FILED AS OF DATE: 20120627
DATE AS OF CHANGE: 20120627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALLEN LEE F MD PhD
CENTRAL INDEX KEY: 0001408474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 12930146
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
4
1
a4.xml
4
X0305
4
2012-06-25
0
0000792977
AMAG PHARMACEUTICALS INC.
AMAG
0001408474
ALLEN LEE F MD PhD
C/O AMAG PHARMACEUTICALS, INC.
100 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
EVP, Chief Medical Officer
Stock Options
14.89
2012-06-25
4
A
0
40000
A
2019-06-25
Common Stock
40000
40000
D
Grant of stock option pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. 25% of this option will vest and become exercisable on June 25, 2013, the first anniversary of the grant, and thereafter the remainder will vest and become exercisable in equal 6.25% quarterly installments through June 25, 2016.
Price is not applicable.
Nancy R. Smith, attorney-in-fact
2012-06-27